Viewing Study NCT00839956


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-06-26 @ 7:16 PM
Study NCT ID: NCT00839956
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2009-02-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None DS Stage I Plasma Cell Myeloma View
None DS Stage II Plasma Cell Myeloma View
None DS Stage III Plasma Cell Myeloma View
Keywords: